Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/35442
Title: | Exploring the impact of providing men with information about potential prostate cancer treatment options prior to receiving biopsy results. | Authors: | Wootten A.;Frydenberg M. ;Pillay B.;Moon D.;Meyer D.;Crowe H.;Mann S.;Howard N. | Monash Health Department(s): | Urology | Institution: | (Pillay, Crowe, Howard, Wootten) Epworth Prostate Centre, Epworth Healthcare, Melbourne, VIC, Australia (Pillay, Crowe, Howard) Urology, Royal Melbourne Hospital, Melbourne, VIC, Australia (Pillay) Psychosocial Oncology Program, Peter MacCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC 3000, Australia (Moon) Epworth Centre for Robotic Surgery, Epsworth Healthcare, Melbourne, VIC, Australia (Moon, Mann, Frydenberg) Australian Urology Associates, Melbourne, VIC, Australia (Moon) University of Melbourne, Melbourne, VIC, Australia (Meyer) School of Health Sciences, Swinburne University of Technology, Melbourne, VIC, Australia (Crowe, Wootten) Australian Prostate Centre, North Melbourne, VIC, Australia (Frydenberg) Urology, Monash Health, Melbourne, VIC, Australia (Frydenberg) Clinical Institute of Specialty Surgery, Epworth Healthcare, Melbourne, VIC, Australia (Frydenberg) Department of Surgery, Monash University, Melbourne, VIC, Australia | Issue Date: | 17-Jan-2020 | Copyright year: | 2020 | Publisher: | Springer | Place of publication: | Germany | Publication information: | Supportive Care in Cancer. 28 (2) (pp 507-514), 2020. Date of Publication: 01 Feb 2020. | Journal: | Supportive Care in Cancer | Abstract: | Purpose: There is little research assessing the impact of providing men with information about prostate cancer (PCa) treatment options at the time of referral for a prostate biopsy. Study objectives were to determine whether receiving an information booklet about PCa treatment options prior to receiving biopsy results was acceptable to patients, and if receiving this information influenced levels of anxiety, depression, distress, and treatment decisional conflict. Method(s): Between June 2016 and September 2017, a randomised block design was used to allocate patients from an Australian urology practice into the intervention or control group. Patients in the intervention group were provided with written information about treatment options for localised PCa prior to their biopsy. Outcome measures including the Distress Thermometer, Generalised Anxiety Disorder-7, Patient Health Questionnaire-9, and Decisional Conflict Scale were completed pre-biopsy and 2-3 weeks post-biopsy. Ninety-eight patients referred for an initial prostate biopsy for an elevated PSA test or suspicious digital rectal exam participated in the study (response rate = 78%). Result(s): Multimodal repeated-measures analyses showed no significant differences between control and intervention groups in changes in distress, anxiety, or depression from pre- to post-biopsy, and in decisional conflict post-diagnosis (all p >.05). Thirty-five (87%) patients believed that the resource made it easier to understand subsequent explanation of treatment options, and 51 patients (98%) who received the intervention preferred to be given information at that time. Conclusion(s): Providing patients with information about treatment options prior to biopsy did not impact on changes in psychological distress and decisional conflict post-biopsy. However, the majority of patients preferred to be given such information at this time point.Copyright © 2019, Springer-Verlag GmbH Germany, part of Springer Nature. | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1007/s00520-019-04847-5 | PubMed URL: | 31065839 [http://www.ncbi.nlm.nih.gov/pubmed/?term=31065839] | ISSN: | 0941-4355 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/35442 | Type: | Article | Subjects: | prostate biopsy anxiety cancer patient conflict digital rectal examination distress syndrome medical information patient decision making patient referral prostate cancer prostate specific antigen |
Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.